/Investor DB

Arcus Ventures

Venture capital

New York · Seed–Series A · 4 people tracked

Find your way into Arcus Ventures

Each arrow is one introduction. Sign up to fill in the first one.

178 people can intro you to Chad

Ask Sharon Tan to introduce you to Chad C. Hellmann

You →Sharon · together at NLS Pharmaceutics AG →Chad

165 people can intro you to Irene

Ask Jamie Chen to introduce you to Irene Susmano

You →Jamie · together at ARC VENTURES →Irene

58 people can intro you to Steven

Ask Sam Okafor to introduce you to Steven Soignet

You →Sam · together at Vanderbilt University School of Medicine →Steven

Sign up to find every way you can get introduced to Arcus Ventures

  • Your email: who you already know at Arcus Ventures, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Arcus Ventures team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Arcus Ventures is a New York-based healthcare investment firm that backs oncology companies developing biopharmaceuticals, drug delivery platforms, medical devices, diagnostics, and related services. The firm's team brings backgrounds in clinical medicine, drug development, hospital management, healthcare consulting, and private equity.

Stage
Seed–Series A
HQ
New York, New York, US
Instruments
Equity
Founded
2007
Tracked investments
3

Team · 4 people

from public directories

What they invest in

from 2 of 3 portfolio companies

Healthtech ×2Biotech ×1

HQs:United States×2

Investments · 3 tracked

founders shown can be your intro path

By year:2016 · 12014 · 12011 · 13 dated

Exosome DiagnosticsinSeries B · Mar 2014 · $27M

BiotechHealthtechCambridge, US

James McCullough(Executive Officer, Director)William Kelly(Chief Financial Officer and Secretary of Issuer)Thomas McLain(Chief Executive Officer and Director of Issuer)Sara Barrington(Executive Officer)

BoardJoseph Boystak(Director)inGeert-Jan Mulder(Director)in

Co-investorsForbionNGN Capital

T2 Biosystemst2biosystems.cominSep 2016

HealthtechLexington, US

Michael Cima, Ph.D.(Director)Rahul Dhanda(Senior Vice President, Corporate Development)inJohn McDonough(Chief Executive Officer)inTom Lowery, Ph.D.(Chief Scientific Officer)Michael Gibbs, Esq.(Vice President and General Counsel)Joanne Spadoro, Ph.D.(Chief Operating Officer)in

Co-investorsAisling CapitalAPERTURE Venture PartnersJohnson & Johnson Innovation – JJDCPolaris PartnersRA Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

MI Bioresearch

Frequently asked questions

What stage does Arcus Ventures invest at?
Arcus Ventures invests at the Seed, Series A stages.
What sectors does Arcus Ventures focus on?
Arcus Ventures focuses on Biotech, Healthtech, Medical Devices.
Where is Arcus Ventures located?
Arcus Ventures is headquartered in New York, US.

Co-investors · 3

Forbion

Forbion is a global venture capital firm focused on advancing biotech innovations and other sustainable solutions aimed at improving human and planetary health.

Both backed · 1
Beringea

Beringea is a transatlantic venture capital firm that partners with entrepreneurs to scale high-growth businesses, drawing on funds and networks in both the U.S. and the U.K.

Both backed · 1
MI Bioresearch
$3M – $10M
Arboretum Ventures

Arboretum Ventures is a Midwest-based venture capital firm focused on the healthcare industry, investing in early-stage companies across medical devices, life science tools and diagnostics, tech-enabled care delivery, and pharma adjacencies.

$5M – $15M

Firms observed investing alongside Arcus Ventures, from public investor directories. Shared companies are the overlap with Arcus Ventures's recorded portfolio.

Similar investors

Featured in lists